{"organizations": [], "uuid": "bd3df37c3381e3b4bdb4db160b7e66f3a72b0d36", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-xbiotech-announces-upcoming-phase/brief-xbiotech-announces-upcoming-phase-2-clinical-studies-in-dermatology-idUSFWN1RT0AZ", "country": "US", "domain_rank": 408, "title": "BRIEF-XBiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-16T15:18:00.000+03:00", "replies_count": 0, "uuid": "bd3df37c3381e3b4bdb4db160b7e66f3a72b0d36"}, "author": "", "url": "https://www.reuters.com/article/brief-xbiotech-announces-upcoming-phase/brief-xbiotech-announces-upcoming-phase-2-clinical-studies-in-dermatology-idUSFWN1RT0AZ", "ord_in_thread": 0, "title": "BRIEF-XBiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology", "locations": [], "entities": {"persons": [], "locations": [{"name": "dermat", "sentiment": "none"}], "organizations": [{"name": "reuters staff    xbiotech inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 21 PM / Updated 10 minutes ago BRIEF-XBiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology Reuters Staff \n  XBiotech Inc: \n* XBIOTECH ANNOUNCES UPCOMING PHASE 2 CLINICAL STUDIES IN DERMATOLOGY \n* XBIOTECH INC - CO WOULD EVALUATE A NEW SUBCUTANEOUS FORMULATION OF COâ€™S TRUE HUMAN MONOCLONAL ANTIBODY, MABP1, IN TWO SEPARATE PHASE 2 STUDIES \n* XBIOTECH INC - UPCOMING PHASE 2 CLINICAL STUDIES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (AD) AND HIDRADENITIS SUPPURATIVA (HS)  ", "external_links": [], "published": "2018-04-16T15:18:00.000+03:00", "crawled": "2018-04-16T15:40:48.024+03:00", "highlightTitle": ""}